Compare SMWB & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMWB | TOI |
|---|---|---|
| Founded | 2007 | 2007 |
| Country | Israel | United States |
| Employees | N/A | 641 |
| Industry | Computer Software: Programming Data Processing | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 300.5M | 304.4M |
| IPO Year | 2021 | N/A |
| Metric | SMWB | TOI |
|---|---|---|
| Price | $4.39 | $4.74 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $4.00 | ★ $6.67 |
| AVG Volume (30 Days) | 928.6K | ★ 1.7M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.07 | $30.15 |
| Revenue Next Year | $11.17 | $25.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.22 | $2.02 |
| 52 Week High | $10.75 | $4.90 |
| Indicator | SMWB | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 71.46 | 62.82 |
| Support Level | $2.44 | $3.10 |
| Resistance Level | $7.82 | $4.88 |
| Average True Range (ATR) | 0.32 | 0.29 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 83.91 | 81.64 |
Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.